Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice.

Prieto-Fernández E, Aransay AM, Royo F, González E, Lozano JJ, Santos-Zorrozua B, Macias-Camara N, González M, Garay RP, Benito J, Garcia-Orad A, Falcón-Pérez JM.

Theranostics. 2019 Jun 19;9(16):4567-4579. doi: 10.7150/thno.31502. eCollection 2019.

2.

Pharmacotherapeutic approaches to treating depression during the perimenopause.

Garay RP, Charpeaud T, Logan S, Hannaert P, Garay RG, Llorca PM, Shorey S.

Expert Opin Pharmacother. 2019 Oct;20(15):1837-1845. doi: 10.1080/14656566.2019.1645122. Epub 2019 Jul 29. Review.

PMID:
31355688
3.

Vaccinating against depression or anxiety: is it plausible?

Garay RP.

Expert Opin Biol Ther. 2017 May;17(5):525-528. doi: 10.1080/14712598.2017.1300654. Epub 2017 Mar 10. No abstract available.

PMID:
28277809
4.

Investigational drugs in recent clinical trials for treatment-resistant depression.

Garay RP, Zarate CA Jr, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM.

Expert Rev Neurother. 2017 Jun;17(6):593-609. doi: 10.1080/14737175.2017.1283217. Epub 2017 Jan 29. Review.

5.

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

Garay RP, Grossberg GT.

Expert Opin Investig Drugs. 2017 Jan;26(1):121-132. doi: 10.1080/13543784.2017.1267726. Epub 2016 Dec 11. Review.

PMID:
27936965
6.

Investigational drugs for treating agitation in persons with dementia.

Garay RP, Citrome L, Grossberg GT, Cavero I, Llorca PM.

Expert Opin Investig Drugs. 2016 Aug;25(8):973-83. doi: 10.1080/13543784.2016.1193155. Epub 2016 Jun 7. Review.

PMID:
27232589
7.

Usefulness of new and traditional serum biomarkers in children with suspected appendicitis.

Benito J, Acedo Y, Medrano L, Barcena E, Garay RP, Arri EA.

Am J Emerg Med. 2016 May;34(5):871-6. doi: 10.1016/j.ajem.2016.02.011. Epub 2016 Feb 12.

PMID:
26935221
8.

Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.

Garay RP, Citrome L, Samalin L, Liu CC, Thomsen MS, Correll CU, Hameg A, Llorca PM.

Expert Opin Pharmacother. 2016;17(7):921-36. doi: 10.1517/14656566.2016.1149164. Epub 2016 Feb 19. Review.

PMID:
26831200
10.

Potential serotonergic agents for the treatment of schizophrenia.

Garay RP, Bourin M, de Paillette E, Samalin L, Hameg A, Llorca PM.

Expert Opin Investig Drugs. 2016;25(2):159-70. doi: 10.1517/13543784.2016.1121995. Epub 2015 Dec 15. Review.

PMID:
26576669
11.

Investigational drugs for anxiety in patients with schizophrenia.

Garay RP, Samalin L, Hameg A, Llorca PM.

Expert Opin Investig Drugs. 2015 Apr;24(4):507-17. doi: 10.1517/13543784.2014.987339. Epub 2014 Nov 25. Review.

PMID:
25423603
12.

Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment.

Garay RP, Llorca PM, Young AH, Hameg A, Samalin L.

Drug Discov Today. 2014 Nov;19(11):1792-1800. doi: 10.1016/j.drudis.2014.07.010. Epub 2014 Jul 24. Review.

PMID:
25066425
13.

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents.

Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P.

Expert Opin Drug Deliv. 2012 Nov;9(11):1319-23. doi: 10.1517/17425247.2012.720969. Epub 2012 Aug 30.

PMID:
22931049
14.

Therapeutic perspectives on uricases for gout.

Garay RP, El-Gewely MR, Labaune JP, Richette P.

Joint Bone Spine. 2012 May;79(3):237-42. doi: 10.1016/j.jbspin.2012.01.004. Epub 2012 Feb 25. Review.

PMID:
22366146
15.

[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France].

Bergmann JF, Lloret-Linares C, Rami A, Cohen AT, Garay RP, Kakkar AK, Goldhaber SZ, Deslandes B, Tapson VF, Anderson FA; pour les investigateurs de l’étude Endorse France.

Presse Med. 2011 Dec;40(12 Pt 1):e528-37. doi: 10.1016/j.lpm.2011.06.023. Epub 2011 Oct 2. French.

PMID:
21964042
16.

In vitro effect of calcium dobesilate on oxidative/inflammatory stress in human varicose veins.

Alda O, Valero MS, Pereboom D, Serrano P, Azcona JM, Garay RP.

Phlebology. 2011 Dec;26(8):332-7. doi: 10.1258/phleb.2010.010052. Epub 2011 Jun 24.

PMID:
21705478
17.

Impact of an educational program on the management of bipolar disorder in primary care.

Rouillon F, Gasquet I, Garay RP, Lancrenon S.

Bipolar Disord. 2011 May;13(3):318-22. doi: 10.1111/j.1399-5618.2011.00916.x.

PMID:
21676135
18.

[Pharmacological management of anxiety in patients suffering from schizophrenia].

Baylé FJ, Blanc O, De Chazeron I, Lesturgeon J, Lançon C, Caci H, Garay RP, Llorca PM.

Encephale. 2011 May;37 Suppl 1:S83-9. doi: 10.1016/j.encep.2010.08.009. Epub 2010 Oct 12. Review. French.

PMID:
21600338
19.

Protein kinase A signalling is involved in the relaxant responses to the selective β-oestrogen receptor agonist diarylpropionitrile in rat aortic smooth muscle in vitro.

Valero MS, Pereboom D, Barcelo-Batllory S, Brines L, Garay RP, Alda JO.

J Pharm Pharmacol. 2011 Feb;63(2):222-9. doi: 10.1111/j.2042-7158.2010.01203.x.

PMID:
21235586
20.

Screening for bipolar disorder in patients consulting general practitioners in France.

Rouillon F, Gasquet I, Garay RP, Lancrenon S.

J Affect Disord. 2011 May;130(3):492-5. doi: 10.1016/j.jad.2010.10.037. Epub 2010 Nov 24.

PMID:
21109306
21.

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.

Azorin JM, Bowden CL, Garay RP, Perugi G, Vieta E, Young AH.

Neuropsychiatr Dis Treat. 2010 Mar 24;6:37-46.

22.

Endothelium-independent vasorelaxation by the selective alpha estrogen receptor agonist propyl pyrazole triol in rat aortic smooth muscle.

Alda JO, Valero MS, Pereboom D, Gros P, Garay RP.

J Pharm Pharmacol. 2009 May;61(5):641-6. doi: 10.1211/jpp/61.05.0013.

PMID:
19406003
23.

Cyamemazine metabolites: effects on human cardiac ion channels in-vitro and on the QTc interval in guinea pigs.

Crumb W, Benyamina A, Arbus C, Thomas GP, Garay RP, Hameg A.

J Pharm Pharmacol. 2008 Nov;60(11):1507-13. doi: 10.1211/jpp/60.11.0012.

PMID:
18957172
24.

[Management of comorbid bipolar disorder and alcohol dependence].

Brousse G, Garay RP, Benyamina A.

Presse Med. 2008 Jul-Aug;37(7-8):1132-7. doi: 10.1016/j.lpm.2007.09.020. Epub 2008 Feb 25. Review. French.

PMID:
18296020
25.

Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug.

Chabannes JP, Bazin N, Leguay D, Nuss P, Peretti CS, Tatu P, Hameg A, Garay RP, Ferreri M.

Eur Psychiatry. 2008 Jan;23(1):8-13. Epub 2007 Oct 26.

PMID:
17964764
26.

Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.

Arbus C, Benyamina A, Llorca PM, Baylé F, Bromet N, Massiere F, Garay RP, Hameg A.

Eur J Pharm Sci. 2007 Dec;32(4-5):357-66. Epub 2007 Sep 14.

PMID:
17951033
27.

What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension?

Garay RP, Alda O.

Pathophysiology. 2007 Dec;14(3-4):167-70. Epub 2007 Oct 17.

PMID:
17942286
28.

Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.

Benyamina A, Arbus C, Nuss P, Garay RP, Neliat G, Hameg A.

Eur J Pharmacol. 2008 Jan 14;578(2-3):142-7. Epub 2007 Oct 2.

PMID:
17936750
29.

Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.

Garay RP, Viens P, Bauer J, Normier G, Bardou M, Jeannin JF, Chiavaroli C.

Eur J Pharmacol. 2007 Jun 1;563(1-3):1-17. Epub 2007 Feb 17. Review.

PMID:
17383632
30.

Role of chloride transport proteins in the vasorelaxant action of nitroprusside in isolated rat aorta.

Valero M, Pereboom D, Garay RP, Alda JO.

Eur J Pharmacol. 2006 Dec 28;553(1-3):205-8. Epub 2006 Sep 23.

PMID:
17074318
31.
32.

Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent.

Garay RP, Chiavaroli C, Hannaert P.

Am J Ther. 2006 May-Jun;13(3):236-47. Review.

PMID:
16772766
33.

Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs.

Crumb W, Llorca PM, Lancon C, Thomas GP, Garay RP, Hameg A.

Eur J Pharmacol. 2006 Feb 27;532(3):270-8. Epub 2006 Feb 21.

PMID:
16494862
34.

Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.

Lemoine P, Kermadi I, Garcia-Acosta S, Garay RP, Dib M.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):131-7. Epub 2005 Oct 21.

PMID:
16243418
35.

Calcium dobesilate in the treatment of diabetic retinopathy.

Garay RP, Hannaert P, Chiavaroli C.

Treat Endocrinol. 2005;4(4):221-32.

PMID:
16053339
36.

Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats.

Lameynardie S, Chiavaroli C, Travo P, Garay RP, Parés-Herbuté N.

Eur J Pharmacol. 2005 Mar 7;510(1-2):149-56.

PMID:
15740736
37.

[Role of nitric oxide in the NKCC2 hyperactivity of Dahl "salt-sensitive" rats].

Alvarez-Guerra M, Lou M, Garay RP.

Arch Mal Coeur Vaiss. 2004 Jul-Aug;97(7-8):731-3. French.

PMID:
15506055
38.

The hemostatic agent ethamsylate promotes platelet/leukocyte aggregate formation in a model of vascular injury.

Hernandez MR, Alvarez-Guerra M, Escolar G, Chiavaroli C, Hannaert P, Garay RP.

Fundam Clin Pharmacol. 2004 Aug;18(4):423-30.

PMID:
15312148
39.

Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.

Rota R, Chiavaroli C, Garay RP, Hannaert P.

Eur J Pharmacol. 2004 Jul 14;495(2-3):217-24.

PMID:
15249173
40.

Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells.

Alvarez-Guerra M, Libertus H, Garay RP.

Pulm Pharmacol Ther. 2004;17(4):213-8.

PMID:
15219266
41.

Isoosmotic shrinkage by self-stimulated outward Na-K-Cl cotransport in quail erythrocytes.

Lou JM, Garay RP, Gimenez I, Escanero JF, Alda JO.

Pflugers Arch. 2003 Oct;447(1):64-70. Epub 2003 Sep 2.

PMID:
12955514
42.

Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by ethamsylate.

Hannaert P, Alvarez-Guerra M, Hider H, Chiavaroli C, Garay RP.

Eur J Pharmacol. 2003 Apr 11;466(1-2):207-12.

PMID:
12679158
43.

Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by antioxidants.

Alvarez-Guerra M, Hannaert P, Hider H, Chiavaroli C, Garay RP.

Eur J Pharmacol. 2003 Apr 11;466(1-2):199-205.

PMID:
12679157
44.

Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.

Peinado J, Hameg A, Garay RP, Bayle F, Nuss P, Dib M.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):134-9. Epub 2003 Jan 23.

PMID:
12595954
45.

The hemostatic agent ethamsylate enhances P-selectin membrane expression in human platelets and cultured endothelial cells.

Alvarez-Guerra M, Hernandez MR, Escolar G, Chiavaroli C, Garay RP, Hannaert P.

Thromb Res. 2002 Sep 15;107(6):329-35.

PMID:
12565720
46.

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.

Hameg A, Bayle F, Nuss P, Dupuis P, Garay RP, Dib M.

Biochem Pharmacol. 2003 Feb 1;65(3):435-40.

PMID:
12527336
47.

5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.

Alvarez-Guerra M, Hameg A, Bayle F, Dib M, Garay RP.

Eur J Pharmacol. 2002 Nov 15;454(2-3):235-9.

PMID:
12421652
48.

Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension.

Rivas M, Garay RP, Escanero JF, Cia P Jr, Cia P, Alda JO.

J Nutr. 2002 Jul;132(7):1900-2.

PMID:
12097666
49.

Renal Na-K-Cl cotransporter NKCC2 in Dahl salt-sensitive rats.

Alvarez-Guerra M, Garay RP.

J Hypertens. 2002 Apr;20(4):721-7.

PMID:
11910309
50.

Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.

Hannaert P, Alvarez-Guerra M, Pirot D, Nazaret C, Garay RP.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Mar;365(3):193-9. Epub 2002 Feb 1.

PMID:
11882915

Supplemental Content

Loading ...
Support Center